Browse Newsroom

InsuLIfe Appoints Former Pfizer Executive to Advisory Board

August 12, 2021

InsuLife is pleased to announce the appointment of Roy F. Waldron to our Advisory Board effective immediately. Mr. Waldron brings over 20 years of deep legal and intellectual property protection experience to InsuLife AS.

For almost twenty years, Roy F. Waldron served as the Senior Vice President, Associate General Counsel and Chief Intellectual Property Counsel at Pfizer (retired June 2018), where he led global teams of Pfizer attorneys and professionals in procuring patents, and worked closely with R&D, licensing and business development and Pfizer business units to develop and strengthen intellectual property strategies for products in development. 

“We are very pleased to have Roy join our board and look forward to benefiting from his extensive experience,” said Aage Naerdal, InsuLife Co-Founder and CEO.

Mr. Waldron currently sits on the boards of several pharmaceutical startups and non-profit organizations.  He holds a JD from New York University Law School, a PhD from Yale and a BA from Dartmouth College.

Subscribe for InsuLife News Updates
Sign up to receive the latest InsuLife news, updates and investing information delivered right to your inbox.
Newsletter Form (#1)
InsuLife is a Norwegian company aiming at bringing the unparalleled developmental INS-2301 skin-applied insulin to market.
Learn More
© Copyright 2024 - InsuLife AS, All Rights Reserved